HT-SPOTi: A Rapid Drug Susceptibility Test (DST) to Evaluate Antibiotic Resistance Profiles and Novel Chemicals for Anti-Infective Drug Discovery.
about
Repurposing drugs for treatment of tuberculosis: a role for non-steroidal anti-inflammatory drugs.Early diagnosis and effective treatment regimens are the keys to tackle antimicrobial resistance in tuberculosis (TB): A report from Euroscicon's international TB Summit 2016.Host Antimicrobial Peptides: The Promise of New Treatment Strategies against Tuberculosis.Analogues of Disulfides from Allium stipitatum Demonstrate Potent Anti-tubercular Activities through Drug Efflux Pump and Biofilm Inhibition.Novel Anti-Tuberculosis Nanodelivery Formulation of Ethambutol with Graphene Oxide.Nano-Formulation of Ethambutol with Multifunctional Graphene Oxide and Magnetic Nanoparticles Retains Its Anti-Tubercular Activity with Prospects of Improving Chemotherapeutic Efficacy.
P2860
HT-SPOTi: A Rapid Drug Susceptibility Test (DST) to Evaluate Antibiotic Resistance Profiles and Novel Chemicals for Anti-Infective Drug Discovery.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh
2016年學術文章
@zh-hant
name
HT-SPOTi: A Rapid Drug Suscept ...... Anti-Infective Drug Discovery.
@en
type
label
HT-SPOTi: A Rapid Drug Suscept ...... Anti-Infective Drug Discovery.
@en
prefLabel
HT-SPOTi: A Rapid Drug Suscept ...... Anti-Infective Drug Discovery.
@en
P2093
P2860
P1476
HT-SPOTi: A Rapid Drug Suscept ...... Anti-Infective Drug Discovery.
@en
P2093
Arundhati Maitra
Cynthia A Danquah
Jane Faull
Sanjib Bhakta
Simon Gibbons
P2860
P304
P356
10.1002/9780471729259.MC1708S40
P577
2016-02-08T00:00:00Z